Recent studies reported that DNASE1L3 could inhibit glycolysis in hepatoma cells and promote the tricarboxylic acid cycle involved in PTPN2‐HK2 and CEBPβ‐p53‐PFK1 pathways, thereby inhibiting HCC progression.14, 15. This evidence concerns the gene PFKM and hepatocellular carcinoma.